Journals / Bezmiâlem Science / 2021 / Cilt: 9 - Sayı: 1

Investigation the Relationship Between Body Mass Index and Mortality in COVID-19 Patients

Vücut Kitle İndeksi ile COVİD-19 Hastalarının Mortalitesi Arasındaki İlişkinin İrdelenmesi

Pages
9–12
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In subgroupanalyses, obesity (BMI >30 kg/m2) was more common amongmortality group versus survivors in males older than 60 years old(p=0.03).Conclusion: Obesity with associated disorders are negativeprognostic factors for COVID-19 and should be tackled as the endof the pandemic is obscure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Obesity might be a risk factor for patients withCoronavirus disease-19 (COVID-19).
📊
Key Findings & Data:We aimed to investigate theassociation of the obesity with intensive care need and mortalitycaused by severe acute respiratory syndrome-CoV-2 (SARS-CoV-2)infection in this retrospective cohort.Methods: Between March 11th and May 1st, 135 patients, who weretreated in our clinic, were enrolled in the study.
💡
Conclusion & Impact:In subgroupanalyses, obesity (BMI >30 kg/m2) was more common amongmortality group versus survivors in males older than 60 years old(p=0.03).Conclusion: Obesity with associated disorders are negativeprognostic factors for COVID-19 and should be tackled as the endof the pandemic is obscure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Obesity might be a risk factor for patients withCoronavirus disease-19 (COVID-19). We aimed to investigate theassociation of the obesity with intensive care need and mortalitycaused by severe acute respiratory syndrome-CoV-2 (SARS-CoV-2)infection in this retrospective cohort.Methods: Between March 11th and May 1st, 135 patients, who weretreated in our clinic, were enrolled in the study. Body mass index(BMIs) of the patients were grouped according as WHO criteria(30 kg/m2: obese).Results: Of our patients, 34.1% (n=46) were obese. Mean BMI ofthe mortality group was 31.2 kg/m2 and was not different from thatof the survivors (p=0.09), However, mean BMI of the patients, inwhom intensive care was needed, was 31.2 kg/m2 and higher thanthat of those intensive care was not needed (p=0.04). In subgroupanalyses, obesity (BMI >30 kg/m2) was more common amongmortality group versus survivors in males older than 60 years old(p=0.03).Conclusion: Obesity with associated disorders are negativeprognostic factors for COVID-19 and should be tackled as the endof the pandemic is obscure.

Özet

Amaç: Obezitenin, Koronavirüs hastalığı-19 (COVİD-19) olguları için olumsuz bir risk faktörü olabileceği görülmektedir. Bu retrospektif kohortta, şiddetli akur solunum enfeksiyonu-CoV- 2’nin (SARS-CoV-2) sebep olduğu mortalite ve yoğun bakım ünitesinde takip edilme gereksinimi ile vücut kitle indeksi ilişkisini değerlendirmeyi amaçladık. Yöntemler: 11 Mart-1 Mayıs 2020 tarihleri arasında kliniğimizde takip edilen 135 hasta çalışmaya dahil edildi. Hastaların VKİ değerleri Dünya Sağlık Örgütü’nün belirlediği değerlere göre gruplandırıldı (60 yaş erkek cinsiyet olanlarda sağ kalanlara göre ölenler obezdi (vücut kitle indeksi >30 kg/m2 ) (p=0,03). Sonuç: Obesite, kendisi ve beraberinde getirdiği hastalık yüküyle COVİD-19 gibi bir çok hastalıkta kötü prognostik faktördür. COVİD-19 salgınının ne zaman sonlandırılacağı bilinmezken obezite gibi hastalığın seyri açısından olumsuz faktörlerle mücadele edilmesi gerektiği açıktır.

🔖

Cite This Article

KAÇMAZ, A. B., KOÇ, M. M., SÜMBÜL, B., OKAY, G., DURDU, B., AKKOYUNLU, Y., BÖLÜKÇÜ, S., ÖZMEN, M. E., EKŞİ, Ç. (2022). Investigation the Relationship Between Body Mass Index and Mortality in COVID-19 Patients. Bezmiâlem Science, Cilt: 9 - Sayı: 1, 9–12. https://ajindex.com/articles/463963

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. 2020;382:1708-20
  2. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. International journal of obesity. 2013;37:333-40
  3. Zhang X, Zheng J, Zhang L, Liu Y, Chen GP, Wang L, et al, editors. Systemic inflammation mediates the detrimental effects of obesity on asthma control. Allergy & Asthma Proceedings; 2018
  4. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva: World Health Organization. 16-24 February 2020
  5. Visscher TL, Lakerveld J, Olsen N, Küpers L, Ramalho S, Keaver L, et al. Perceived Health Status: Is Obesity Perceived as a Risk Factor and Disease? Obesity facts. 2017;10:52-60
  6. Ryan DH, Ravussin E, Heymsfield S. COVID 19 and the patient with obesity–the editors speak out. J Obesity. 2020
  7. Lee EH, Wu C, Lee EU, Stoute A, Hanson H, Cook HA, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010;50:1498-504
  8. Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol 2020;8:562-4
  9. Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis 2020
  10. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas- Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab 2020;105
  11. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. J medRxiv 2020:2020.04.23.20076042
  12. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study 2020;201(11):1372-9
  13. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 2020;127:104364
  14. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invas